Literature DB >> 30343578

Comparative Glycomics Study of Cell-Surface N-Glycomes of HepG2 versus LO2 Cell Lines.

Yuyin Han1, Kaijie Xiao1, Zhixin Tian1.   

Abstract

Cell-surface N-glycans play important roles in both inter- and intracellular processes, including cell adhesion and development, cell recognition, as well as cancer development and metastasis; detailed structural characterization of these N-glycans is thus paramount. Here we report our comparative N-glycomics study of cell-surface N-glycans of the hepatocellular carcinoma (HCC) HepG2 cells vs the normal liver LO2 cells. With sequential trypsin digestion of proteins, C18 depletion of peptides without glycosylation, PNGase F digestion of N-glycopeptides, PGC enrichment of N-glycans, CH3I permethylation of the enriched N-glycans, cell-surface N-glycomes of the HepG2 and LO2 cells were analyzed using C18-RPLC-MS/MS (HCD). With spectrum-level FDR no bigger than 1%, 351 and 310 N-glycans were identified for HepG2 and LO2, respectively, with comprehensive structural information (not only monosaccharide composition, but also sequence and linkage) by N-glycan database search engine GlySeeker. The percentage of hybrid N-glycans with tetra-antennary structures was substantially increased in the HepG2 cells. This comprehensive discovery study of differentially expressed cell-surface N-glycans in HepG2 vs LO2 serves as a solid reference for future validation study of glycosylation markers in HCC.

Entities:  

Keywords:  GlySeeker; HepG2 cells; N-glycans; cell-surface; identification

Mesh:

Substances:

Year:  2018        PMID: 30343578     DOI: 10.1021/acs.jproteome.8b00655

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  3 in total

1.  Comparative Glycomics Analysis of Mass Spectrometry Data.

Authors:  Yusen Zhou; Sriram Neelamegham
Journal:  Methods Mol Biol       Date:  2022

2.  Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis.

Authors:  Ying Kong; Hao Chen; Mengyu Chen; Yongshuai Li; Jiarong Li; Qi Liu; Huan Xiong; Tangxi Guo; Yan Xie; Yufeng Yuan; Xiao-Lian Zhang
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

3.  Precision N-glycoproteomics reveals elevated LacdiNAc as a novel signature of intrahepatic cholangiocarcinoma.

Authors:  Jun Li; Ting Zhao; Jing Li; Jiechen Shen; Li Jia; Bojing Zhu; Liuyi Dang; Chen Ma; Didi Liu; Fan Mu; Liangshuo Hu; Shisheng Sun
Journal:  Mol Oncol       Date:  2021-12-18       Impact factor: 7.449

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.